Confronting Covid-19 by exploring the possibility of vaccinating with live SARS-CoV-2 virus itself, via a route that would reduce the incidence of pulmonary complications [version 1; peer review: 2 approved]
This article proposes that one should explore whether the pulmonary complications of Covid-19 can be reduced or avoided by bypassing the airway entry of the SARS-CoV-2 virus. This could possibly be achieved by injecting live SARS-CoV-2 virus intradermal (ID), subcutaneous, intra-muscular (IM) or int...
Main Author: | Etienne Joly |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2020-04-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/9-309/v1 |
Similar Items
-
Development of vaccines for SARS-CoV-2 [version 1; peer review: 2 approved]
by: Wern Hann Ng, et al.
Published: (2020-08-01) -
Electrolyte Disturbances in SARS-CoV-2 Infection [version 2; peer review: 2 approved]
by: Holly Mabillard, et al.
Published: (2020-07-01) -
Interactive SARS-CoV-2 mutation timemaps [version 2; peer review: 1 approved, 2 approved with reservations]
by: René L. Warren, et al.
Published: (2021-06-01) -
Integrated genomic view of SARS-CoV-2 in India [version 1; peer review: 2 approved]
by: Pramod Kumar, et al.
Published: (2020-08-01) -
Characterization of SARS-CoV-2 East Java isolate, Indonesia [version 1; peer review: 2 approved]
by: Fedik Abdul Rantam, et al.
Published: (2021-06-01)